Stephen joined Danforth in 2021 to build and lead West Coast operations, bringing 30 years of experience as an executive officer and board member of life science companies ranging from clinical to commercial stages. In the roles of CFO, CEO and COO, he oversaw wide-ranging operational functions and financial events for both private and public life science companies, including multiple IPOs, private equity, debt and alternative structured financings. He most recently served asCFO of Covalent Health.
Stephen holds a BA in Business Administration from California State University East Bay.
Select Achievements
- Led capital raises with aggregate transaction value of $1 billion, including M&A, debt, equity capital and alternative financing structures
- As interim CEO and CFO of Galena Biopharma, oversaw all operating functions of a publicly-traded, clinical-stage biotech company and executed on the sale of the company
- Served as strategic partner to CEOs and management teams with focus on mentorship and leadership development
- Acted as face of the company to investors, boards and strategic partners
- Managed negotiations for large transactions including commercial, supply chain, M&A and strategic partnerships